Document is current
Any future updates will be listed below
-
Authors
Denkel, Luisa A. http://orcid.org/0000-0003-4005-1315
Schwab, Frank
Clausmeyer, Jörg
Behnke, Michael
Golembus, Jennifer
Wolke, Solvy
Gastmeier, Petra
Geffers, Christine
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00010475 at German Clinical Trials RegisterDocuments that mention this clinical trial
Central-line associated bloodstream infections in intensive care units before and after implementation of daily antiseptic bathing with chlorhexidine or octenidine: a post-hoc analysis of a cluster-randomised controlled trial
https://doi.org/10.1186/s13756-023-01260-w
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (03ZZ0807A)
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 11 May 2022
Accepted: 29 May 2023
First Online: 3 June 2023
Declarations
:
: This study was conducted in compliance with the principles of the Declaration of Helsinki. The institutional ethical review board (IRB) of Charité Universitätsmedizin Berlin (processing number EA1/093/16) granted its approval for this trial at June 2, 2016. The IRB granted a waiver of written informed consent as the study fulfilled all criteria of a cluster-randomised controlled trial (cRCT).
: Not applicable. This study did not include any individual patient data, but analysed aggregated data only.
: All authors have no conflicts of interest to declare. On behalf of all authors, the corresponding author states that there is no conflict of interest. The German Ministry of Education and Research (funder) and companies (Sage Products/Stryker, Schülke) funding products and the investigation of tolerances of bacterial isolates to chlorhexidine and octenidine by an independent laboratory had no role in study design, data collection and analysis, data interpretation, the decision to publish, or the preparation of the manuscript.
